The Beneficial Effects of Levetiracetam on Polyneuropathy in the Early Stage of Sepsis in Rats: Electrophysiological and Biochemical Evidence

REFERENCES

• Bolton CF, Gilbert JJ, Hahn AF, Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47:1223–1231.
   PubMed Web of Science ®Google Scholar
• Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32:140–163.
   PubMed Web of Science ®Google Scholar
• Stevens RD, Dowdy DW, Michaels RK, Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33:1876–1891.
   PubMed Web of Science ®Google Scholar
• Pati S, Goodfellow JA, Iyadurai S, Approach to critical illness polyneuropathy and myopathy. Postgrad Med J. 2008;84:354–360.
   PubMed Web of Science ®Google Scholar
• Hermans G, De Jonghe B, Bruyninckx F, Clinical review: critical illness polyneuropathy and myopathy. Crit Care. 2008;12:238.
   PubMed Web of Science ®Google Scholar
• Tennila A, Salmi T, Pettila V, Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000;26:1360–1363.
   PubMed Web of Science ®Google Scholar
• Guillouet M, Gueret G, Rannou F, Tumor necrosis factor-α downregulates sodium current in skeletal muscle by protein kinase C activation: involvement in critical illness polyneuromyopathy. Am J Physiol Cell Physiol. 2011;301:C1057–C1063.
   Web of Science ®Google Scholar
• Chawla J, Gruener G. Management of critical illness polyneuropathy and myopathy. Neurol Clin. 2010;28:961–977.
   PubMed Web of Science ®Google Scholar
• Cankayali I, Dogan HY, Solak I, Effects of IgM enriched immunoglobulin and fluid replacement on nerve conduction velocity in experimental sepsis. Ulus Travma Acil Cerrahi Derg. 2010;16:9–14.
   PubMed Web of Science ®Google Scholar
• Atis S, Nayci A, Ozge A, N-acetylcysteine protects the rats against phrenic nerve dysfunction in sepsis. Shock. 2006;25:30–35.
   PubMed Web of Science ®Google Scholar
• Ortolani O, Conti A, De Gaudio AR, The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med. 2000;161:1907–1911.
   PubMed Web of Science ®Google Scholar
• Berger MM, Chioléro RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med. 2007;35:S584–S590.
   PubMed Web of Science ®Google Scholar
• Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia. 2002;43:9–18.
   PubMed Web of Science ®Google Scholar
• Poulain P, Margineanu DG. Levetiracetam opposes the action of GABAA antagonists in hypothalamic neurons. Neuropharmacology. 2002;42:346–352.
   PubMed Web of Science ®Google Scholar
• Madeja M, Margineanu DG, Gorji A, Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action? Neuropharmacology. 2003;45:661–671.
   PubMed Web of Science ®Google Scholar
• Lynch BA, Lambeng N, Nocka K, The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861–9866.
   PubMed Web of Science ®Google Scholar
• Costa C, Martella G, Picconi B, Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke. 2006;37:1319–1326.
   PubMed Web of Science ®Google Scholar
• Hanon E, Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure. 2001;10:287–293.
   PubMed Web of Science ®Google Scholar
• Marini H, Costa C, Passaniti M, Levetiracetam protects against kainic acid-induced toxicity. Life Sci. 2004;74:1253–1264.
   PubMed Web of Science ®Google Scholar
• Belcastro V, Pierguidi L, Tambasco N. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy. Brain Dev. 2011;33:289–293.
   PubMed Web of Science ®Google Scholar
• Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock—a review of laboratory models and a proposal. J Surg Res. 1980;29:189–201.
   PubMed Web of Science ®Google Scholar
• Demougeot C, Marie C, Beley A. Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sci. 2000;67:399–410.
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15–27.
   PubMed Web of Science ®Google Scholar
• Bernal ME, Varon J, Acosta P, Oxidative stress in critical care medicine. Int J Clin Pract. 2010;64:1480–1488.
   PubMed Web of Science ®Google Scholar
• Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy—a reappraisal. Clin Neurophysiol. 2001;112:1586–1593.
   PubMed Web of Science ®Google Scholar
• Nayci A, Atis S, Comelekoglu U, Sepsis induces early phrenic nerve neuropathy in rats. Eur Respir J. 2005;26:686–692.
   PubMed Web of Science ®Google Scholar
• Cankayali I, Dogan YH, Solak I, Neuromuscular deterioration in the early stage of sepsis in rats. Crit Care. 2007; 11:R1.
   Web of Science ®Google Scholar
• Novak KR, Nardelli P, Cope TC, Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest. 2009;119:1150–1158.
   PubMed Web of Science ®Google Scholar
• Oliveira AA, Almeida JP, Freitas RM, Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures. Cell Mol Neurobiol. 2007;27:395–406.
   PubMed Web of Science ®Google Scholar
• Zapater P, Moreno J, Horga JF. Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Res. 1997;772:57- 62.
   PubMed Web of Science ®Google Scholar
• Lo AC, Black JA, Waxman SG. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport. 2002;13:1909–1912.
   PubMed Web of Science ®Google Scholar
• Stettner M, Dehmel T, Mausberg AK, Levetiracetam exhibits protective properties on rat Schwann cells in vitro. J Peripher Nerv Syst. 2011;16:250–260.
   PubMed Web of Science ®Google Scholar
• Dubovy P. Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann Anat. 2011;193:267–275.
   PubMed Web of Science ®Google Scholar
• Zindler E, Zipp F. Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol. 2010;24:551–562.
   PubMedGoogle Scholar
• Fang C, Bourdette D, Banker G. Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases. Mol Neurodegener. 2012;7:29.
   PubMed Web of Science ®Google Scholar
• Vogl C, Mochida S, Wolff C, The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol. 2012;82:199–208.
   PubMed Web of Science ®Google Scholar
• Fei G, Guo C, Sun HS, Chronic hypoxia stress-induced differential modulation of heath-shock protein 70 and presynaptic proteins. J Neurochem. 2007; 100: 50–61.
   PubMed Web of Science ®Google Scholar